INTRACHOL

Serial Number 97398455
606

Registration Progress

Application Filed
May 6, 2022
Under Examination
Dec 6, 2022
Approved for Publication
Oct 11, 2022
Published for Opposition
Oct 11, 2022
Registered

Attorney Assistance

Abandonment - No Use Statement Filed
Due: Sep 07, 2025 61 days
Revival assistance for abandoned trademark

Basic Information

Serial Number
97398455
Deadline
September 7, 2025
Description
Trademark Application Revival Due
Filing Date
May 6, 2022
Published for Opposition
October 11, 2022
Abandonment Date
July 7, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 7, 2025
Classes
005

Rights Holder

Protara Therapeutics, Inc.

03
Address
345 Park Avenue South, 3rd Floor
New York, NY 10010

Ownership History

Protara Therapeutics, Inc.

Original Applicant
03
New York, NY

Protara Therapeutics, Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Jared M. Barrett

USPTO Deadlines

Next Deadline
61 days remaining
Abandonment - No Use Statement Filed
Due Date
September 07, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

30 events
Date Code Type Description
Jul 7, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 7, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 26, 2024 EX4G S SOU EXTENSION 4 GRANTED
Nov 25, 2024 EXT4 S SOU EXTENSION 4 FILED
Nov 25, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
May 29, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 28, 2024 EX3G S SOU EXTENSION 3 GRANTED
May 28, 2024 EXT3 S SOU EXTENSION 3 FILED
May 28, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 29, 2023 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 29, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 29, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 29, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 23, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 21, 2023 EX2G S SOU EXTENSION 2 GRANTED
Nov 21, 2023 EXT2 S SOU EXTENSION 2 FILED
Nov 21, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 8, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 6, 2023 EX1G S SOU EXTENSION 1 GRANTED
Mar 6, 2023 EXT1 S SOU EXTENSION 1 FILED
Mar 6, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 6, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 11, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 11, 2022 PUBO A PUBLISHED FOR OPPOSITION
Sep 21, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 8, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 2, 2022 DOCK D ASSIGNED TO EXAMINER
May 10, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 10, 2022 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, choline chloride intravenous preparation for injection, co-administered with parenteral support, for the treatment and prevention of Intestinal Failure Associated Liver Disease (IFALD) also known as total parenteral nutrition (TPN) associated liver disease

Classification

International Classes
005